未登录

P

Peter J. Eggenhuizen

monash university

H指数:14

被引数:1,045

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease

所有细胞都是均一的吗？炎症性肠病的新型基于细胞的再生疗法

International Journal of Molecular Sciences

IF4.9

2026-02-260

OAAI

Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease

炎症性肠病中T细胞表达IL-37及其受体的特征

International Journal of Molecular Sciences

IF4.9

2026-02-050

OAAI

Regulatory T cell therapies: from patient data to biological insights

调节性T细胞疗法：从患者数据到生物学见解

Frontiers in Immunology

IF5.9

2025-10-310

OAAI

Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti-glomerular basement membrane disease antigen

工程化抗原特异性T调节细胞可抑制对抗肾小球基底膜疾病抗原的自身反应性。

KIDNEY INTERNATIONAL

IF12.6

2025-01-010

OAAI

Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study

CLINICAL KIDNEY JOURNAL

IF4.6

2024-09-060

OAAI

Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA

CLINICAL AND EXPERIMENTAL MEDICINE

IF3.5

2024-04-021

OAAI

The Influence of Cross-Reactive T Cells in COVID-19

交叉反应性T细胞对新型冠状病毒肺炎的影响

IF3.9

2024-03-024

OAAI

Smith-specific regulatory T cells halt the progression of lupus nephritis

NATURE COMMUNICATIONS

IF15.7

2024-02-068

OAAI

Single-cell transcriptomics uncover hub genes and cell-cell crosstalk in patients with hypertensive nephropathy

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-12-015

PRE

Development of a radiomics nomogram to predict the treatment resistance of Chinese MPO-AAV patients with lung involvement: a two-center study

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-07-121

OAAI

Sex disparities in clinicopathological features and outcomes of patients with myeloperoxidase-ANCA-associated vasculitis: a retrospective study of 366 cases in a single Chinese center

CLINICAL AND EXPERIMENTAL MEDICINE

IF3.5

2023-07-101

OA

Single-cell RNA sequencing reveals the transcriptomic landscape of kidneys in patients with ischemic acute kidney injury

CHINESE MEDICAL JOURNAL

IF7.3

2023-04-205

OAAI

Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-10-279

OAAI

Coexistence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and IgA nephropathy

抗中性粒细胞胞浆抗体 (ANCA) 相关血管炎 (AAV) 与IgA肾病的共存

IMMUNOLOGIC RESEARCH

IF3.1

2022-10-130

PRE

Intrarenal Single-Cell Sequencing of Hepatitis B Virus Associated Membranous Nephropathy

FRONTIERS IN MEDICINE

IF3

2022-07-223

OAAI

The effect of discontinuation of maintenance therapy in Chinese patients with MPO-ANCA associated vasculitis who were in long-term stable remission

CLINICAL AND EXPERIMENTAL MEDICINE

IF3.5

2022-03-091

PRE

Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria

SARS-CoV-2与病原菌的异源免疫

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-01-2718

OAAI

Patient Survival Between Hemodialysis and Peritoneal Dialysis Among End-Stage Renal Disease Patients Secondary to Myeloperoxidase-ANCA-Associated Vasculitis

继发于髓过氧化物酶-ANCA相关血管炎的终末期肾病患者的血液透析和腹膜透析之间的患者生存率

FRONTIERS IN MEDICINE

IF3

2022-01-144

OAAI

Clinical features and outcomes of anti-neutrophil cytoplasmic autoantibody-associated vasculitis in Chinese childhood-onset patients

CLINICAL AND EXPERIMENTAL MEDICINE

IF3.5

2021-09-224

PREAI

BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-08-0534

OAAI